Insulin Management

Patients who used the Bigfoot Unity Diabetes Management System had glycemic control and reduced diabetes distress.

Control-IQ+ was associated with a greater reduction in glycated hemoglobin compared to a continuous glucose monitor alone.

These findings challenge the common assumption that older adults might struggle to use more advance medical devices.

Children with type 1 diabetes who watched educational videos and played games had improved glycemic control and quality of life.

MannKind announced results from the INHALE-1 study that examined Afrezza in children and adolescents with diabetes.

Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.

Two phase 3 trials demonstrated that once-weekly insulin efsitora is as effective as daily insulin in lowering HbA1c in both type 1 (T1D) and type 2 diabetes (T2D).